Illumina $ILMN is a biotech company that focuses on genetic research. It has been mostly bullish in 2017 separated by 3 periods of consolidation. Price is breaking above the most recent one.ILMN Daily Chart(click to enlarge)Breakout:- The daily chart shows the 2017 drive-up from 120 to 215. - Note that there has been 3 periods of consolidation, and the latest one is an ascending triangle.- Also note that price has broke above the resistance around 214, though it's not a strong breakout so far.- Still, the fact that this is a persistent uptrend in the medium-term, and has broken above a consolidation suggests ILMN is in a bullish continuation.- If price can hold above 210 on a pullback, we should expect ILMN to extend to new highs and return to the 2015 highs just above 240.- On the weekly chart, note that price was bullish before the period of bearish correction in 2015 through 2016. - Essentially, 2017 appears to be the year of bullish continuation that could go into 2018 as price reaches back at highs around 240.ILMN Weekly Chart(click to enlarge)